IL149363A0 - Combination chemotherapy - Google Patents

Combination chemotherapy

Info

Publication number
IL149363A0
IL149363A0 IL14936300A IL14936300A IL149363A0 IL 149363 A0 IL149363 A0 IL 149363A0 IL 14936300 A IL14936300 A IL 14936300A IL 14936300 A IL14936300 A IL 14936300A IL 149363 A0 IL149363 A0 IL 149363A0
Authority
IL
Israel
Prior art keywords
combination chemotherapy
chemotherapy
combination
Prior art date
Application number
IL14936300A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL149363A0 publication Critical patent/IL149363A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL14936300A 1999-11-10 2000-11-03 Combination chemotherapy IL149363A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16488999P 1999-11-10 1999-11-10
US22256100P 2000-08-03 2000-08-03
PCT/US2000/030377 WO2001034131A2 (en) 1999-11-10 2000-11-03 Combination chemotherapy

Publications (1)

Publication Number Publication Date
IL149363A0 true IL149363A0 (en) 2002-11-10

Family

ID=26860956

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14936300A IL149363A0 (en) 1999-11-10 2000-11-03 Combination chemotherapy

Country Status (17)

Country Link
EP (1) EP1229916A2 (xx)
JP (1) JP2003513912A (xx)
KR (1) KR20020060226A (xx)
CN (1) CN1387438A (xx)
AR (1) AR026400A1 (xx)
AU (1) AU1583201A (xx)
CA (1) CA2386876A1 (xx)
GT (1) GT200000194A (xx)
HU (1) HUP0203153A3 (xx)
IL (1) IL149363A0 (xx)
NZ (1) NZ518668A (xx)
PA (1) PA8506201A1 (xx)
PE (1) PE20011028A1 (xx)
PL (1) PL355170A1 (xx)
SV (1) SV2001000212A (xx)
UY (1) UY26431A1 (xx)
WO (1) WO2001034131A2 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20022216A3 (cs) * 2001-07-02 2003-05-14 Warner-Lambert Company Kombinační chemoterapie
PE20050206A1 (es) * 2003-05-26 2005-03-26 Schering Ag Composicion farmaceutica que contiene un inhibidor de histona deacetilasa
DK1696898T3 (en) 2003-12-02 2016-02-22 Univ Ohio State Res Found ZN2 + -CHELATING DESIGN-BASED SHORT-CHAIN FAT ACIDS AS AN UNKNOWN CLASS OF HISTONDEACETYLASE INHIBITORS
US7951780B2 (en) 2004-02-25 2011-05-31 Astellas Pharma Inc. Antitumor agent
EP1802341A1 (en) * 2004-07-16 2007-07-04 Pfizer Products Inc. Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
EP2415382B1 (en) 2010-08-06 2012-08-29 Electrolux Home Products Corporation N.V. Table top dishwasher
EP3461488A1 (en) 2017-09-27 2019-04-03 Onxeo Combination of a dbait molecule and a hdac inhibitor for treating cancer
EP3461480A1 (en) 2017-09-27 2019-04-03 Onxeo Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
WO2023041805A1 (en) 2021-09-20 2023-03-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for improving the efficacy of hdac inhibitor therapy and predicting the response to treatment with hdac inhibitor
WO2023194441A1 (en) 2022-04-05 2023-10-12 Istituto Nazionale Tumori Irccs - Fondazione G. Pascale Combination of hdac inhibitors and statins for use in the treatment of pancreatic cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases

Also Published As

Publication number Publication date
PA8506201A1 (es) 2002-12-11
WO2001034131A3 (en) 2002-05-10
GT200000194A (es) 2002-05-03
HUP0203153A2 (hu) 2003-01-28
PL355170A1 (en) 2004-04-05
CN1387438A (zh) 2002-12-25
KR20020060226A (ko) 2002-07-16
SV2001000212A (es) 2001-10-25
UY26431A1 (es) 2000-12-29
CA2386876A1 (en) 2001-05-17
EP1229916A2 (en) 2002-08-14
HUP0203153A3 (en) 2005-01-28
AR026400A1 (es) 2003-02-12
NZ518668A (en) 2004-04-30
AU1583201A (en) 2001-06-06
PE20011028A1 (es) 2001-10-12
WO2001034131A2 (en) 2001-05-17
JP2003513912A (ja) 2003-04-15

Similar Documents

Publication Publication Date Title
DE50002490D1 (en) Polyester-polyetherblockcopolymere
DE50008011D1 (en) Thixotropierungsmittel
DE50002614D1 (en) Sigma-delta-modulator
IL143939A0 (en) Combination chemotherapy
GB0011903D0 (en) Combination chemotherapy
DE50000137D1 (en) Spirofluorenopyrane
DE59909975D1 (en) Testleck
IL149363A0 (en) Combination chemotherapy
HK1030332A2 (en) ???
DE60001313D1 (en) Imidazodiazepinderivate
DE10081629D2 (en) Seilzugbefestigung
DE60044882D1 (en) Ie
DE50009469D1 (en) Common-rail-injektor
HUP0200274A2 (en) Fitting
DE50010757D1 (en) Stilbenaufheller
DE50012999D1 (en) Stirnwandisolation
DE50008218D1 (en) Common-rail-injektor
DE60004080D1 (en) Centroidintegration
GB9913742D0 (en) Horologe improvement
AU141428S (en) Turnpiece
DE50012739D1 (en) Thermovliesstoff
DE50008219D1 (en) Common-rail-injektor
HUP0201655A2 (en) Opening-limiting fitting
DE50005334D1 (en) Tricyclische benzoylcyclohexandion-derivate
DE60004674D1 (en) Carbonylierungsreaktionen